Member Updates

No results found for this search.

• [Re] Imagining a Sustainable Future

  The Kendall Square Association’s 14th Annual Meeting Celebration is on Thursday, October 20th at the new MIT Museum from 5:00 – 7:30 PM. This evening will begin with networking, food,...

• • COVID-19

  Moderna says its vaccine prevented 100 percent of COVID-19 cases in study of adolescents 12 to 17

• 

  • Diversity + Equity + Inclusion

  Meet Ian Kilpatrick, Head of Corporate Partnerships, Innercity Weightlifting

• 

  • Diversity + Equity + Inclusion

  Meet Melissa DesRavines, Human Resources Manager, Turner Construction

• 

  • Restaurants + Bars

  Meet Alex Gladwell, Co-Founder of Restaurant Mutual Worker Aid

• • Restaurants + Bars

  Lamplighter Unveils Official Plans for Brewery at Cambridge Crossing in 2021

• 

  • Diversity + Equity + Inclusion
  • KSA News
  • KSA Programming

  Inclusion Drives Innovation Info Sessions: Fall 2021

  Inclusion Drives Innovation was designed by and for Kendall Square Association members focused on building anti-racist organizations. Our method? Empowering participants to expedite the rate of change in their organizations...

• • Biopharma

  Biogen to make experimental ALS drug available to dying patients

• Broad expands COVID-19 viral sequencing efforts for variant surveillance in the Northeast

• New List of Beer Gardens & Reopening Dates

• MIT Studied Kendall Square Foot Traffic; Could Lead to New Urban Planning

• New Study Indicates Moderna Vaccine 95% Effective After 6 Months

• • Technology

  In $19.7 billion deal for Nuance, Microsoft sees big opportunity in health care and artificial intelligence

• • Biotech + Life Sciences

  Sanofi Snatches Up Tidal Therapeutics in $470 Million Deal

• • Diversity + Equity + Inclusion

  Hundreds of Companies Unite to Oppose Voting Limits, but Others Abstain

• Broad Institute launches $300 million initiative to fight diseases with artificial intelligence

• • Biopharma
  • COVID-19

  The new mRNA vaccines from Pfizer and Moderna to fight the coronavirus are based on a technology that could transform the future of medicine.

• • Technology

  Companies responsible for the technology that help bring shows and live events to our TVs, computers, and phones get recognition at the Emmys, including Kendall's Akamai.

• The new mRNA vaccines from Pfizer and Moderna to fight the coronavirus are based on a technology that could transform the future of medicine.

• • Biopharma

  Biological sensors developed by Glympse Bio, a startup that spun out of the lab of MIT Professor Sangeeta Bhatia, could help clinicians make decisions for individual patients.

• • COVID-19

  Last week, the Broad Genomics team processed its 10 millionth COVID-19 test! Approximately 1 in every 20 tests performed in the US daily are processed at the Broad Institute.

• • COVID-19
  • Diversity + Equity + Inclusion

  Community leaders are expressing major concerns about the racial disparity in the COVID-19 vaccine rollout.

• • Restaurants + Bars

  We're excited to share that sweetgreen is opening in Kendall Square at 201 Galileo Galilei Way on Monday, February 1!

• BioMed will build a new lab campus in Somerville by Assembly. This new site will house 1.3 million square feet of development. Hear Bill Kane, Executive Vice President of BioMed’s East Coast and U.K. Markets, speak on the project here.

• • Transportation

  New York Times editorial board published an op ed detailing the urgent need to fund public transit across the country. Public transit systems urgently need more funding so they can continue to provide this important public service: getting to and from where they need to go.

• With the Biden Administration gearing up, we want to celebrate leaders in our Kendall community and across Massachusetts, who will be joining the Biden/Harris team in Washington, D.C.

• • COVID-19

  Last week, the Gillette Stadium became a large-scale COVID-19 vaccination clinic run by CIC Health. They will aim to vaccinate 500 people a day with the Moderna vaccine and hope to double that total each successive week.

• • Biotech + Life Sciences
  • Education + Research Incubators

  Last week, LabCentral announced LabCentral Ignite: a platform for collective investment and what they believe will be a “spark” for systemic change in STEM Education, talent development/placement, and entrepreneurial support in the biotech industry.

• MIT's Vice President for Research, Maria Zuber, has been named co-chair of the President’s Council of Advisors on Science and Technology.

• • Biotech + Life Sciences

  Eric S. Lander, Founding Director of the Broad Institute of MIT and Harvard, will be the Director of the Office of Science and Technology Policy and serve as the White House Science Advisor to President Joe Biden following the inauguration.

• • Biotech + Life Sciences

  FUJIFILM Diosynth Biotechnologies will establish a new process development and manufacturing facility for viral vectors and advanced therapies in the Greater Boston area. This will be their third location for viral vector CDMO services.

• Alexandria Real Estate is closing on a blockbuster deal acquiring the former Sears distribution center in Fenway. This $1.52 billion deal will allow them to transform the place into a lab site and a future lab development site.

• • Biotech + Life Sciences

  Moderna has tapped veteran Amgen executive Corinne Le Goff to spearhead their vaccine rollout as chief commercial officer.

• The City of Cambridge is $125,000 away from raising $5 million for the Mayor's Disaster Relief Fund! Donate today, so they can reopen applications and assist more families and residents in Cambridge during the pandemic.

• • COVID-19

  Pfizer's leading COVID-19 vaccine got authorized for emergency use in the United States and is out for distribution this week.

• Kendall’s Pandemic Resilience: A Collaboration Story

  The stresses of 2020 have reaffirmed how critical connectivity, serendipity, and collaborations are in problem solving and advancing our individual and collective interests. As 2020 winds down, we wanted to...

• 

  • Kendall Collective

  Meet Elizabeth Bramson-Boudreau—CEO & Publisher, MIT Tech Review

• • Biopharma

  Biogen, placing a major bet on a once-failed treatment, is paying $1.53 billion for the commercial rights to a Sage Therapeutics’ oral depression drug, zuranolone.

• Alnylam Pharmaceuticals won FDA approval for its third medicine in as many years. The drug, Oxlumo, is approved for a rare disorder called primary hyperoxaluria type 1, which can cause kidney and bladder stones.

• • COVID-19

  Moderna is asking federal regulators to authorize emergency use of its experimental COVID-19 vaccine.

• • Restaurants + Bars

  Now is a crucial time to show support for Kendall's restaurants and retailers. With foot traffic down 90% in Kendall, we all need to go out of our way to buy gift cards, place orders to pick up, and spend money with these stores that are working so hard to hang on.

• • COVID-19

  After announcing its experimental COVID-19 vaccine to be 95% effective, Pfizer asked the FDA to authorize their COVID-19 vaccine.

• 

  • Kendall Collective

  Meet Stephen Pitt—Head of JLABS, US North East, Johnson & Johnson Innovation

• • Culture

  Help your team stay connected and engaged with Private Group Zoom Yoga and Guided Meditation Classes with Healthy Yoga Life.

• • COVID-19

  The Boston Globe's Shirley Leung and Tim Logan detail Massachusetts' options for exploring a second lockdown and the implications this can have on our economy.

• • COVID-19

  Pfizer is getting close to having a COVID-19 vaccine ready for the public but the drug maker, the government, and the public health community faces a new challenge: quickly making millions of doses of the vaccine.

• • COVID-19

  Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective

• 

  • Kendall Collective

  Meet Jen Faigel, Executive Director—CommonWealth Kitchen

• The Massachusetts Life Science Center (MLSC) has named Kenneth Turner their new President and Chief Executive Officer.

• • Transportation

  The MBTA will announce which services will be prioritized and protected for the year ahead and which will have proposed changes.

• • Biotech + Life Sciences

  As a platinum sponsor of LabCentral, Bristol Myers Squibb has awarded Lucy Therapeutics and Vincere Biosciences a 2020 Golden Ticket!

• • COVID-19

  Pfizer announced that the early analysis of its trial COVID-19 vaccine was more than 90% effective in preventing the disease among volunteers.

• 

  • Kendall Collective

  Meet Eric Quadrino, Partner—Sulmona Restaurant

• • Biotech + Life Sciences

  Synlogic's CEO Aoife Brennan shares her experience working with a growing team during the pandemic.

• • COVID-19

  Moderna's CEO has announced that their COVID-19 vaccine might be available as early as December for emergency use.

• • Biopharma
  • Biotech + Life Sciences

  Last week, Anne Heatherington, Ph.D., senior vice president and head of Data Sciences Institute at Takeda shared that competitive barriers that typically limit the sharing of data have been broken down during the global response.

• • COVID-19

  CIC Health is offering COVID-19 testing to organizations and individuals in an accessible, easy, and fast way.

• • COVID-19
  • Diversity + Equity + Inclusion

  Moderna has been working with local communities to reach a diverse population for its COVE Phase 3 study. They've now enrolled 28,618 participants in the study and approximately 34.5% of them are from diverse communities.

• • COVID-19

  If Pfizer's COVID-19 vaccine study shows positive results by the end of the month they would have data on its safety by the third week of November.

• Last week, Life Science Cares hosted its Impact Breakfast Re-Imagined! The community came together to raise $605K to help them continue their work dismantling poverty and increasing equity in our communities.

• • Culture
  • Retail + Shopping

  Cambridge Marriott has reopened its doors on October 2. Their "Commitment to Clean" is their greatest focus and they look forward to reconnecting with the Kendall community in the weeks and months ahead.

• • Technology

  With the pandemic taking a toll on people’s mental health, Facebook is launching a collection of resources to help support its users.

• • Biotech + Life Sciences

  "Science has long been the country’s greatest engine for health, economic prosperity, and national security. Today, the need for science is greater than ever as we face an avalanche of challenges unlike at any time in history," says Eric Lander, president and founder of the Broad Institute in his opinion piece for the Boston Globe.

• 

  • Kendall Collective

  Meet Jon Feinman—CEO, InnerCity Weightlifting

• CIC Cambridge is looking for mentors and partners for their first-ever bootcamp focused on high potential early stage Japanese life science / healthcare startups.

• • Biotech + Life Sciences

  A new Broad Institute study has found key differences between human and lab animal brains, which could help scientists improve studies on neuropsychiatric diseases. 

• • Diversity + Equity + Inclusion

  Just-A-Start's Executive Director, Carl Nagy-Koechlin, and Board Chair, Peter Munkenbeck expressed their opposition to the President's Executive Order curtailing anti-racism, diversity, and harassment training.

• 

  • Kendall Collective

  Meet Vanessa Brown—Chief People Officer, CIC

• • COVID-19

  Researchers at MIT and Broad Institute have been working on a CRISPR-based diagnostic that can produce COVID-19 test results in 30 minutes to an hour.

• • Technology

  Google was the first major company to become carbon neutral, and this past decade they've achieved 100% renewable energy. Looking ahead to the next decade, they aim to be the first company to operate carbon-free by 2030.

• • Biopharma

  Johnson & Johnson entered its final stage of clinical trials for its COVID-19 vaccine. What differentiates their vaccine candidate from others is that it does not need to be frozen and may require just one injection.

• This summer, Cambridge Savings Bank and DivcoWest each donated $25,000 to the Summer Empowerment Program for Cambridge youth.

• Philips has been recognized by Forbes as the 11th best place to work in Massachusetts according to employees.

• The Board of Directors of The Charles Stark Draper Laboratory, Inc. has announced that William LaPlante is their new President and Chief Executive Officer.

• • Biotech + Life Sciences

  Amgen has launched its 2020 LabCentral Golden Ticket competition!

• • Biotech + Life Sciences

  Biogen announced that they are investing $250 million in a 20-year initiative to accelerate action on the greatest challenges of our time: climate change, public health, and equity.

• 

  • Kendall Collective

  Meet Tarikh Campbell, Diversity & Inclusion Business Program Manager, Microsoft

• • Biopharma
  • Biotech + Life Sciences

  Nine CEOs signed a pledge outlining a united commitment to sustain the integrity of the scientific process as they work toward potential regulatory filings and approvals of the first COVID-19 vaccines.

• • Biopharma
  • Biotech + Life Sciences

  Bayer has entered a collaboration agreement with Recursion Pharmaceuticals to strengthen AI-guided drug discovery and advance new treatments for fibrotic diseases of the lung, kidney, heart, and more.

• • Biotech + Life Sciences
  • Coworking

  There's been an increase of interest in the biotech space since the outset of the COVID-19 pandemic. LabCentral is experiencing this first hand – See what Johannes Fruehauf, founder and president, of LabCentral has to say about this industry's growth.

• • COVID-19

  Pfizer's CEO, Albert Bourla said there's a chance that a COVID-19 vaccine could be distributed to the American public by the end of this October.

• • COVID-19

  The Power of Proximity Persists — even through a Pandemic

  In March, organizations all over the country scrambled to adapt their businesses as the global pandemic made its way into the U.S. As a world leader in innovation, Kendall has...

• • Restaurants + Bars

  Steve "Nookie" Postal made the decision to have Commonwealth go into hibernation starting September 20.

• Johnson & Johnson Innovation has put together a medical countermeasure innovation collaboration called Blue Knight.

• • COVID-19

  Since March, Broad Institute's Genomics team has processed over 1.2 million COVID-19 tests for nursing homes, hospitals, and higher education.

• • COVID-19

  MIT is entering their next phase of campus reopening and are making sure they ramp up their testing simultaneously.

• • COVID-19

  Moderna has found that its experimental COVID-19 vaccine shows promising results for older adults who are at higher risk of hospitalization and death.

• 

  Meet Andrea Windhausen, Community Manager, BioMed Realty

• In order to provide increased voting options in response to COVID-19, early voting for the State Primary Election on September 1st will be available to all voters Aug. 22-28, 2020.

• Bench International, a leading global executive search firm, announced that it will be opening a new hub located in Kendall Square.

• Last week, Bristol Myers Squibb announced that they plan to lease 360,000 square feet of commercial space in one of Cambridge Crossing's new buildings.

• Tango Therapeutics has expanded its collaboration with Gilead Sciences to develop a new generation of targeted cancer therapies.

• Verve Therapeutics collaborated with Broad Institute to create a process for COVID-19 surveillance testing. This is another example of Kendall companies collaborating to create smart solutions to our greatest challenges, like working from home.

• The antibodies that help the human body fight against COVID-19 may be able to help others. Find out if you qualify to donate plasma today.

• LabCentral companies raise $1.1 billion since going virtual in mid-March.

• Sanofi secured a $2.1 billion deal with the U.S. government to supply them with 100 million doses of its experimental vaccine.

• Applications for Unpitch BIO 2020 are now open for early-stage biotech entrepreneurs!

• MIT List Visual Arts Center continue to grow MIT's Public Art Collection on campus, and even though they are currently closed, you can still visit it all on their Public Art Map virtually.

• 

  • Culture

  The MIT List Visual Arts Center boasts one of the most active Percent-for-Art programs in the country.

• The Bristol Myers Squibb LabCentral Golden Ticket contest helps emerging biotech companies advance their research, by providing winners with a year of bench space within LabCentral’s incredible facility, along with access to the scientific expertise of BMS scientists. Contest runs through August 10th.

• Cambridge announces small business recycling program expansion.

• A "Golden Ticket" opportunity with Lab Central.

  Astellas Venture Management LLC, a venture capital subsidiary of Astellas Pharma Inc., and LabCentral are collaborating on their latest “Golden Ticket Competition.” A Golden Ticket offers entrepreneurial scientists or emerging biotechnology start-ups one-year usage...

• • COVID-19

  Today, Moderna's COVID-19 vaccine will be entering its most important phase of testing.

  This 30,000-person trial will detect several different signs of efficacy.

• MIT President, L. Rafael Reif, writes for the New York Times highlighting the importance of international scholars to America's innovation and competitiveness.

  On July 8, educational leaders MIT and Harvard filed a lawsuit against the Trump administration’s plan to strip visas from foreign students whose courses are entirely online. Last week, the White...

• • COVID-19

  There are 11 coronavirus vaccines to keep our eye on these days, including Moderna, Pfizer, Johnson & Johnson, Sanofi, and more.

• MIT and Harvard filed a lawsuit against the new ICE regulation which would strip visas from foreign students whose courses are entirely online.

  Foreign students are a vital asset to the Kendall ecosystem especially at this time when we are all focused on creating a more diverse, equitable, and inclusive future.

• • Biotech + Life Sciences

  Biogen completes the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of aducanumab, an investigational treatment for Alzheimer’s disease.

• 

  Get your hard hats ready! Click to check out these exciting construction projects coming soon to Kendall Square.

• Cambridge-based Carmine Therapeutics has officially inked a research collaboration with Takeda Pharmaceuticals to develop and commercialize non-viral gene therapies for two rare diseases.

  This $900M deal will allow Takeda to option licensing both programs after preclinical proof-of-concept studies are concluded, before taking over clinical development and commercialization.

• • Diversity + Equity + Inclusion

  A group of black executives created the New Commonwealth Racial Equity and Social Justice Fund.

  This fund has a goal of tackling longstanding racial inequity and social justice issues in the Greater Boston Area. Fund leaders include Pamela Everhart, Senior Vice President of Fidelity Investments, and Quincy Miller, President...

• 

  • Retail + Shopping

  Your Local Grocery Store

  Café du Pays’ spot on Cardinal Medeiros Ave has a long and storied history. Since the building’s original 1894 construction, it’s been a bodega, a gentlemen’s bar, a speakeasy, two...

• • COVID-19

  Novartis responding to COVID-19

  Paul Aliu, Global Head of Medical Governance at Novartis, has his team working on identifying existing treatments for COVID-19 patients in the short term as others look for a vaccine. Read...

• • Education + Research Incubators

  The CIC, home to hundreds of Kendall Square startups, has gone touchless.

  They have put sensors in their main entrances to open doors with the simple wave of a hand. CIC has been a leader in building thorough and transparent protocols for employees' safe return to work.

• • Biotech + Life Sciences

  The Pfizer Breakthrough Growth Initiative

  In June, Pfizer announced that it had launched a new initiative for investing in biotechnology companies and committed up to $500 million to fund the effort. The Pfizer Breakthrough Growth...

• 

  • Restaurants + Bars

  After being closed for three months, the best Jewish deli, Mamaleh's Delicatessen, is open again!

  With a great new menu to choose from, you’re now able to order delivery or takeout on Wednesdays through Sundays between 11am – 6pm.

• • Biopharma

  Moderna CEO sees ‘high probability’ of success with Covid-19 vaccine

  Recent history suggests a new vaccine entering human clinical trials has about a 1-in-3 chance of getting FDA approval. Stephane Bancel, chief executive of Moderna, pegs the chances of his company’s novel coronavirus vaccine at closer to 80% to 90%.

• • Diversity + Equity + Inclusion

  Kendall Together: A Vision for Community Inclusion

  Kendall Square Association’s 12th Annual Meeting Kendall Together was a powerful moment for our innovation ecosystem–bringing our community together and celebrating our successes amidst global crises, and looking with optimism to the...

• 

  • Coworking
  • New to Kendall

  CIC opens a new location at 245 Main

  The third CIC building in their Cambridge campus, features 90,000 square feet of creative office and event space for innovators of all stripes to work, collide, and connect.

• • COVID-19

  Bristol Myers Squibb offers free access to all branded medicine to patients who have lost health insurance due to COVID-19

  To help patients that have recently lost their health insurance due to COVID-19, Bristol Myers Squibb has expanded their patient support programs by offering access to all branded BMS medicine for free.

• • COVID-19

  Biogen Foundation donates $10 million to provide immediate relief for communities affected by COVID-19

  The Biogen Foundation is donating $10 million to provide immediate relief for communities affected by COVID-19. The funding will be used to address immediate critical needs, with the majority of donations going to support non-profit organizations that are working to address critical issues like expanding testing options, easing the strain on our medical systems, providing training and protection for front line health workers and ensuring people have access to necessities like food.

• • Biotech + Life Sciences

  Pfizer business head details new $500M project for investing in public biotechs

  In June, Pfizer announced that it had launched a new initiative for investing in biotechnology companies and committed up to $500 million to fund the effort, which focuses on internal medicine, inflammation and immunology, cancer, rare diseases, vaccines and hospital treatments.

• • Outdoors
  • Placemaking

  50 Teams, 6 Nonprofits, 1 Challenge

  The 2019 Kendall Square Challenge was a huge success because in Kendall — when we work together, there is nothing we can’t achieve. This year’s Kendall Square Challenge was bigger,...

• • KSA News

  New Power Drives Kendall Square: Learn how at our Annual Meeting

  New Power, by Jeremy Heimans and Henry Timms, feels like it was written for Kendall Square, one of the world’s most powerful epicenters of technological innovation. Kendall Square has fundamentally transformed...

• • Diversity + Equity + Inclusion
  • KSA News
  • Transportation

  Grow your network, up your game, change the world in Kendall Square

  As a Kendall Square Association (KSA) member, you can get things done that simply cannot be done alone. Our Learning Communities (formerly known as Committees) provide a forum to collaborate...

• When Tech Has a Field Day

  The event that got 300 Kendall Square tech and life science workers outside for an afternoon of fun — to benefit six nonprofits. Tech and life science workers weren’t the...